Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Trial Profile

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2010

At a glance

  • Drugs Esomeprazole/naproxen; Naproxen
  • Indications Musculoskeletal pain; Rheumatic disorders
  • Focus Pharmacokinetics
  • Sponsors POZEN
  • Most Recent Events

    • 29 Jan 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top